Close Menu
Home › Food Allergy Dx Firm AllerGenis, Luminex Ink Test Development Deal

Food Allergy Dx Firm AllerGenis, Luminex Ink Test Development Deal

Jan 16, 2019
|
staff reporter

NEW YORK (360Dx) – Food allergy diagnostic developer AllerGenis today announced a non-exclusive deal with Luminex for use of that company's xMAP technology to develop, market, and sell a precision food allergy diagnostic assay.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Immunoassays

  1. BioMérieux Reports 11 Percent Revenue Growth in Q4

  2. Snibe Diagnostic Receives CE Mark for SARS-CoV-2 Kits, Immunoassay System

  3. Avacta Eyes Diagnostic Applications for Alternative to Antibody-Based Reagents

    Premium

  4. Mologic, Institut Pasteur de Dakar to Develop Ebola Rapid Diagnostic Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.